cat 55135 1 ap Search Results


cd16 polyclonal antibody  (Bioss)
94
Bioss cd16 polyclonal antibody
Cd16 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd16 polyclonal antibody/product/Bioss
Average 94 stars, based on 1 article reviews
cd16 polyclonal antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
anti α sma  (Proteintech)
96
Proteintech anti α sma
Anti α Sma, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti α sma/product/Proteintech
Average 96 stars, based on 1 article reviews
anti α sma - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
smooth muscle actin polyclonal antibody  (Proteintech)
96
Proteintech smooth muscle actin polyclonal antibody
Smooth Muscle Actin Polyclonal Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/smooth muscle actin polyclonal antibody/product/Proteintech
Average 96 stars, based on 1 article reviews
smooth muscle actin polyclonal antibody - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
cat 55135 1 ap  (Proteintech)
96
Proteintech cat 55135 1 ap
Cat 55135 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cat 55135 1 ap/product/Proteintech
Average 96 stars, based on 1 article reviews
cat 55135 1 ap - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
α sma  (Proteintech)
96
Proteintech α sma
(A) EPIC algorithm was used to analyze immune cells in PC tissues from the TCGA cohort. (B) The positive association between COX-2/ALOX5 expression and CAF levels in PC tissues from TCGA cohort. (C) PC tissues with high COX-2 expression exhibited up-regulated FAP expression. (D) PC tissues with high ALOX5 expression exhibited up-regulated FAP expression. (E) Conditioned medium (CM) derived from PC cells treated with both DMSO or schizandrin A was collected and utilized to treat normal fibroblasts (NFs) with a 90% vimentin positive rate. (F) Immunofluorescence analysis indicated that NFs cells cultured with CM from schizandrin A treatment-PC cells exhibited lower FAP <t>and</t> <t>α-SMA.</t> (G) Mode pattern of the subcutaneous tumor formation test. (H) Tumors derived from NFs and SW1990 cells after schizandrin A demonstrated reduced tumor volume and weight. (I) Immunohistochemical analysis of tumor tissues revealed a lower expression rate <t>of</t> <t>α-SMA</t> and FAP in tumors derived from NFs and SW1990 cells treated with schizandrin A compared to those treated with DMSO. **, P<0.01.
α Sma, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/α sma/product/Proteintech
Average 96 stars, based on 1 article reviews
α sma - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
primary antibodies against α-sma  (Wuhan Sanying Biotechnology)
90
Wuhan Sanying Biotechnology primary antibodies against α-sma
(A) EPIC algorithm was used to analyze immune cells in PC tissues from the TCGA cohort. (B) The positive association between COX-2/ALOX5 expression and CAF levels in PC tissues from TCGA cohort. (C) PC tissues with high COX-2 expression exhibited up-regulated FAP expression. (D) PC tissues with high ALOX5 expression exhibited up-regulated FAP expression. (E) Conditioned medium (CM) derived from PC cells treated with both DMSO or schizandrin A was collected and utilized to treat normal fibroblasts (NFs) with a 90% vimentin positive rate. (F) Immunofluorescence analysis indicated that NFs cells cultured with CM from schizandrin A treatment-PC cells exhibited lower FAP <t>and</t> <t>α-SMA.</t> (G) Mode pattern of the subcutaneous tumor formation test. (H) Tumors derived from NFs and SW1990 cells after schizandrin A demonstrated reduced tumor volume and weight. (I) Immunohistochemical analysis of tumor tissues revealed a lower expression rate <t>of</t> <t>α-SMA</t> and FAP in tumors derived from NFs and SW1990 cells treated with schizandrin A compared to those treated with DMSO. **, P<0.01.
Primary Antibodies Against α Sma, supplied by Wuhan Sanying Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against α-sma/product/Wuhan Sanying Biotechnology
Average 90 stars, based on 1 article reviews
primary antibodies against α-sma - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
anti-e-cadherin  (Becton Dickinson)
90
Becton Dickinson anti-e-cadherin
(A) EPIC algorithm was used to analyze immune cells in PC tissues from the TCGA cohort. (B) The positive association between COX-2/ALOX5 expression and CAF levels in PC tissues from TCGA cohort. (C) PC tissues with high COX-2 expression exhibited up-regulated FAP expression. (D) PC tissues with high ALOX5 expression exhibited up-regulated FAP expression. (E) Conditioned medium (CM) derived from PC cells treated with both DMSO or schizandrin A was collected and utilized to treat normal fibroblasts (NFs) with a 90% vimentin positive rate. (F) Immunofluorescence analysis indicated that NFs cells cultured with CM from schizandrin A treatment-PC cells exhibited lower FAP <t>and</t> <t>α-SMA.</t> (G) Mode pattern of the subcutaneous tumor formation test. (H) Tumors derived from NFs and SW1990 cells after schizandrin A demonstrated reduced tumor volume and weight. (I) Immunohistochemical analysis of tumor tissues revealed a lower expression rate <t>of</t> <t>α-SMA</t> and FAP in tumors derived from NFs and SW1990 cells treated with schizandrin A compared to those treated with DMSO. **, P<0.01.
Anti E Cadherin, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-e-cadherin/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
anti-e-cadherin - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
55135 1 ap  (Proteintech)
96
Proteintech 55135 1 ap
(A) EPIC algorithm was used to analyze immune cells in PC tissues from the TCGA cohort. (B) The positive association between COX-2/ALOX5 expression and CAF levels in PC tissues from TCGA cohort. (C) PC tissues with high COX-2 expression exhibited up-regulated FAP expression. (D) PC tissues with high ALOX5 expression exhibited up-regulated FAP expression. (E) Conditioned medium (CM) derived from PC cells treated with both DMSO or schizandrin A was collected and utilized to treat normal fibroblasts (NFs) with a 90% vimentin positive rate. (F) Immunofluorescence analysis indicated that NFs cells cultured with CM from schizandrin A treatment-PC cells exhibited lower FAP <t>and</t> <t>α-SMA.</t> (G) Mode pattern of the subcutaneous tumor formation test. (H) Tumors derived from NFs and SW1990 cells after schizandrin A demonstrated reduced tumor volume and weight. (I) Immunohistochemical analysis of tumor tissues revealed a lower expression rate <t>of</t> <t>α-SMA</t> and FAP in tumors derived from NFs and SW1990 cells treated with schizandrin A compared to those treated with DMSO. **, P<0.01.
55135 1 Ap, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/55135 1 ap/product/Proteintech
Average 96 stars, based on 1 article reviews
55135 1 ap - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
rabbit anti-α-sma antibody  (Proteintech)
90
Proteintech rabbit anti-α-sma antibody
(A) EPIC algorithm was used to analyze immune cells in PC tissues from the TCGA cohort. (B) The positive association between COX-2/ALOX5 expression and CAF levels in PC tissues from TCGA cohort. (C) PC tissues with high COX-2 expression exhibited up-regulated FAP expression. (D) PC tissues with high ALOX5 expression exhibited up-regulated FAP expression. (E) Conditioned medium (CM) derived from PC cells treated with both DMSO or schizandrin A was collected and utilized to treat normal fibroblasts (NFs) with a 90% vimentin positive rate. (F) Immunofluorescence analysis indicated that NFs cells cultured with CM from schizandrin A treatment-PC cells exhibited lower FAP <t>and</t> <t>α-SMA.</t> (G) Mode pattern of the subcutaneous tumor formation test. (H) Tumors derived from NFs and SW1990 cells after schizandrin A demonstrated reduced tumor volume and weight. (I) Immunohistochemical analysis of tumor tissues revealed a lower expression rate <t>of</t> <t>α-SMA</t> and FAP in tumors derived from NFs and SW1990 cells treated with schizandrin A compared to those treated with DMSO. **, P<0.01.
Rabbit Anti α Sma Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti-α-sma antibody/product/Proteintech
Average 90 stars, based on 1 article reviews
rabbit anti-α-sma antibody - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
acta2 (3f9) monoclonal antibody  (Bioss)
94
Bioss acta2 (3f9) monoclonal antibody
(A) EPIC algorithm was used to analyze immune cells in PC tissues from the TCGA cohort. (B) The positive association between COX-2/ALOX5 expression and CAF levels in PC tissues from TCGA cohort. (C) PC tissues with high COX-2 expression exhibited up-regulated FAP expression. (D) PC tissues with high ALOX5 expression exhibited up-regulated FAP expression. (E) Conditioned medium (CM) derived from PC cells treated with both DMSO or schizandrin A was collected and utilized to treat normal fibroblasts (NFs) with a 90% vimentin positive rate. (F) Immunofluorescence analysis indicated that NFs cells cultured with CM from schizandrin A treatment-PC cells exhibited lower FAP <t>and</t> <t>α-SMA.</t> (G) Mode pattern of the subcutaneous tumor formation test. (H) Tumors derived from NFs and SW1990 cells after schizandrin A demonstrated reduced tumor volume and weight. (I) Immunohistochemical analysis of tumor tissues revealed a lower expression rate <t>of</t> <t>α-SMA</t> and FAP in tumors derived from NFs and SW1990 cells treated with schizandrin A compared to those treated with DMSO. **, P<0.01.
Acta2 (3f9) Monoclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/acta2 (3f9) monoclonal antibody/product/Bioss
Average 94 stars, based on 1 article reviews
acta2 (3f9) monoclonal antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

Image Search Results


(A) EPIC algorithm was used to analyze immune cells in PC tissues from the TCGA cohort. (B) The positive association between COX-2/ALOX5 expression and CAF levels in PC tissues from TCGA cohort. (C) PC tissues with high COX-2 expression exhibited up-regulated FAP expression. (D) PC tissues with high ALOX5 expression exhibited up-regulated FAP expression. (E) Conditioned medium (CM) derived from PC cells treated with both DMSO or schizandrin A was collected and utilized to treat normal fibroblasts (NFs) with a 90% vimentin positive rate. (F) Immunofluorescence analysis indicated that NFs cells cultured with CM from schizandrin A treatment-PC cells exhibited lower FAP and α-SMA. (G) Mode pattern of the subcutaneous tumor formation test. (H) Tumors derived from NFs and SW1990 cells after schizandrin A demonstrated reduced tumor volume and weight. (I) Immunohistochemical analysis of tumor tissues revealed a lower expression rate of α-SMA and FAP in tumors derived from NFs and SW1990 cells treated with schizandrin A compared to those treated with DMSO. **, P<0.01.

Journal: medRxiv

Article Title: Schizandrin A suppressed pancreatic cancer proliferation and cancer associated fibroblast activation via inhibiting the COX-2/ALOX5 shunting

doi: 10.1101/2024.10.09.24315180

Figure Lengend Snippet: (A) EPIC algorithm was used to analyze immune cells in PC tissues from the TCGA cohort. (B) The positive association between COX-2/ALOX5 expression and CAF levels in PC tissues from TCGA cohort. (C) PC tissues with high COX-2 expression exhibited up-regulated FAP expression. (D) PC tissues with high ALOX5 expression exhibited up-regulated FAP expression. (E) Conditioned medium (CM) derived from PC cells treated with both DMSO or schizandrin A was collected and utilized to treat normal fibroblasts (NFs) with a 90% vimentin positive rate. (F) Immunofluorescence analysis indicated that NFs cells cultured with CM from schizandrin A treatment-PC cells exhibited lower FAP and α-SMA. (G) Mode pattern of the subcutaneous tumor formation test. (H) Tumors derived from NFs and SW1990 cells after schizandrin A demonstrated reduced tumor volume and weight. (I) Immunohistochemical analysis of tumor tissues revealed a lower expression rate of α-SMA and FAP in tumors derived from NFs and SW1990 cells treated with schizandrin A compared to those treated with DMSO. **, P<0.01.

Article Snippet: Subsequent procedures involved additional washing with PBS, incubation with the suitable primary antibody including α-SMA (1:50, Cat no. 55135-1-AP, Proteintech, Wuhan, China), and FAP (1:100, Cat no. #66562, CST, USA) in a humidified chamber at 4°C, followed by overnight incubation, washing, and incubation with the appropriate secondary antibody for 2 hours at room temperature.

Techniques: Expressing, Derivative Assay, Immunofluorescence, Cell Culture, Immunohistochemical staining